| |
| |
|
| Insider
Information: |
Venkataraman Ganesh |
| Relationship: |
COO & CSO |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
495,145 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,985,210 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
495,145 |
|
|
| Total
Value |
$25,985,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Momenta Pharmaceuticals Inc |
MNTA |
COO & CSO |
2018-08-21 |
495,145 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
173 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-26 |
4 |
AS |
$12.58 |
$2,302 |
D/D |
(183) |
426,069 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-23 |
4 |
AS |
$13.64 |
$2,810 |
D/D |
(206) |
410,087 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-11-26 |
4 |
AS |
$10.58 |
$2,179 |
D/D |
(206) |
409,488 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-20 |
4 |
AS |
$12.62 |
$2,612 |
D/D |
(207) |
426,460 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-23 |
4 |
AS |
$13.90 |
$2,891 |
D/D |
(208) |
410,686 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-02-25 |
4 |
AS |
$12.43 |
$2,585 |
D/D |
(208) |
426,252 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-02-22 |
4 |
AS |
$15.11 |
$3,188 |
D/D |
(211) |
412,168 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-05-21 |
4 |
AS |
$13.87 |
$2,927 |
D/D |
(211) |
410,894 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-08-21 |
4 |
AS |
$13.78 |
$2,908 |
D/D |
(211) |
410,293 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2012-11-20 |
4 |
AS |
$10.96 |
$2,313 |
D/D |
(211) |
409,694 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-02-25 |
4 |
AS |
$17.47 |
$3,686 |
D/D |
(211) |
363,892 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-05-23 |
4 |
AS |
$12.09 |
$2,551 |
D/D |
(211) |
394,437 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-08-25 |
4 |
AS |
$11.45 |
$2,416 |
D/D |
(211) |
393,781 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2014-11-25 |
4 |
AS |
$11.67 |
$2,462 |
D/D |
(211) |
393,125 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-02-24 |
4 |
AS |
$13.56 |
$2,861 |
D/D |
(211) |
436,598 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-11-21 |
4 |
AS |
$15.01 |
$3,182 |
D/D |
(212) |
402,403 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-08-23 |
4 |
AS |
$14.90 |
$3,159 |
D/D |
(212) |
424,774 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-05-20 |
4 |
AS |
$18.55 |
$3,951 |
D/D |
(213) |
412,285 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2011-08-19 |
4 |
AS |
$15.67 |
$3,338 |
D/D |
(213) |
402,688 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-05-23 |
4 |
AS |
$13.03 |
$2,788 |
D/D |
(214) |
425,421 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-05-15 |
4 |
AS |
$19.96 |
$4,291 |
D/D |
(215) |
389,418 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-08-17 |
4 |
AS |
$21.67 |
$4,681 |
D/D |
(216) |
388,569 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2015-11-17 |
4 |
AS |
$17.65 |
$3,812 |
D/D |
(216) |
387,729 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-05-15 |
4 |
AS |
$13.33 |
$2,893 |
D/D |
(217) |
425,852 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Senior V.P., Research |
• – – |
2013-05-21 |
4 |
AS |
$12.83 |
$2,784 |
D/D |
(217) |
425,635 |
0 |
- |
|
173 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
